View in EDS HTML Full Text PDF Full Text

Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.

Saved in:
Bibliographic Details
Title: Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.
Authors: Creed, T. J.1 (AUTHOR), Norman, M. R.1 (AUTHOR), Probert, C. S. J.2 (AUTHOR), Harvey, R. F.3 (AUTHOR), Shaw, I. S.3 (AUTHOR), Smithson, J.4 (AUTHOR), Anderson, J.5 (AUTHOR), Moorghen, M.6 (AUTHOR), Gupta, J.6 (AUTHOR), Shepherd, N. A.7 (AUTHOR), Dayan, C. M.1 (AUTHOR), Hearing, S. D.2 (AUTHOR)
Source: Alimentary Pharmacology & Therapeutics. Jul2003, Vol. 18 Issue 1, p65-75. 11p. 1 Chart.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02692813
DOI:10.1046/j.1365-2036.2003.01639.x